Ipsc-derived pancreatic progenitors
Ipsc-derived pancreatic progenitors has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Oct 26, 2026: “Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors”.
1 paper studies it1 findingUpdated
1 new paper in 30 daysSee all 1 papers on ipsc-derived pancreatic progenitors
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funder: Russian Science Foundation
- Animals1
What did studies of ipsc-derived pancreatic progenitors find?
1Studies of ipsc-derived pancreatic progenitors measured one outcome, fibrotic capsule thickness.
Fibrotic capsule thickness
downin rats1
1 study
Fibrotic capsule thickness
downin rats1
Ipsc-derived pancreatic progenitors decrease fibrotic capsule thickness in rats Following transplantation.
“IPS-∆B2M-PP implants exhibited the thinnest fibrotic capsules and minimal lymphocytic infiltration.”
AnimalsFollowing transplantationB2M-knockout, alginate-encapsulatedomentum
Cells